🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter randomized, double-blind, placebo-controlled Phase 2 ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2023-06-28
Trial ID
NCT05531656
This is a multi-center, randomized, double-blind, placebo-controlled, paral...
Status
Completed
Location
21st Century Neurology/ Xenoscience Inc.
Start Date
2018-10-10
Trial ID
NCT03507790
This an open label study to assess the pharmacokinetics of CT1812 in normal...
Status
Completed
Location
Accel Clinical Research
Start Date
2022-02-15
Trial ID
NCT05248672
Treatments Being Tested
This is a Phase 2, prospective, multicenter, randomized, double-masked, pla...
Status
Terminated
Location
Phoenix Retina Associates
Start Date
2023-06-16
Trial ID
NCT05893537
Treatments Being Tested
This is a double-blind, placebo controlled, ascending dose, multi-cohort tr...
Status
Completed
Location
Nucleus Network Limited
Start Date
2015-09
Trial ID
NCT02570997
Study to Evaluate the Safety and Tolerability of Oral CT1812 in Subjects wi...
Status
Completed
Location
Yale University School of Medicine
Start Date
2018-03-28
Trial ID
NCT03493282
Treatments Being Tested
Multi-center, randomized, double-blind, placebo-controlled, 6- month study ...
Status
Completed
Location
Barrow Neurological Institute
Start Date
2022-05-19
Trial ID
NCT05225415
Treatments Being Tested
This is a single-site, randomized, double-blind, placebo-controlled, 29-day...
Status
Completed
Location
Brain Research Center
Start Date
2020-07-09
Trial ID
NCT04735536
This is a multi-center, randomized, double-blind, placebo-controlled, paral...
Status
Completed
Location
Dr. Phillip Morris
Start Date
2016-09
Trial ID
NCT02907567
Open-label, single-dose study to assess the absorption, metabolism, excreti...
Status
Completed
Location
Celerion
Start Date
2021-12-31
Trial ID
NCT05225389
Treatments Being Tested